Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China
The quality of inpatient care for COPD in China showed deficiencies in diagnostics, disease assessment, and patient education. Prescription of inhaled LABDs at discharge was a key quality measure that significantly reduced short-term readmission or mortality, highlighting its importance. Standardized protocols and clinician training are essential to improve patient outcomes.
Authors
- Mingdie Wang
- Zhenyu Liang (ORCID: https://orcid.org/0000-0002-8746-315X)
- Wanyi Jiang
- Aiqi Song
- Mei Jiang (ORCID: https://orcid.org/0000-0002-7393-2664)
- Xiaoyan Chen (ORCID: https://orcid.org/0000-0003-0729-3785)
- Lingling Wang (ORCID: https://orcid.org/0000-0003-0272-2974)
- Jiawei Chen (ORCID: https://orcid.org/0000-0001-5383-1359)
- Fengyan Wang (ORCID: https://orcid.org/0000-0001-5737-0625)
- Yuqi Li (ORCID: https://orcid.org/0000-0001-9298-1990)
- Rongchang Chen (ORCID: https://orcid.org/0000-0001-7050-7876)
- Hui Zeng (ORCID: https://orcid.org/0000-0003-2025-844X)
- Heng Zhong
- Weijuan Shi
Institutions
- The Fourth People's Hospital (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- National Supercomputing Center in Shenzhen (CN)
- AstraZeneca (Singapore) (SG)
- AstraZeneca (Germany) (DE)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/copd.s510613
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Guangzhou Medical University
- State Key Laboratory of Respiratory Disease
- National Natural Science Foundation of China